SAN FRANCISCO, Oct. 19, 2021 (GLOBE NEWSWIRE) — PepperLime Health Acquisition Corporation (the “Company”), a Cayman Islands exempted firm that may be a clean examine firm fashioned for the aim of getting into right into a merger, share trade, asset acquisition, share buy, reorganization or related business mixture with a number of companies, right now introduced the closing of its preliminary public providing of 15,000,000 models at a worth of $10.00 per unit. Total gross proceeds from the providing had been $150 million earlier than deducting underwriting reductions and commissions and different providing bills payable by the Company. The Company has granted the underwriter a 45-day choice to buy as much as a further 2,250,000 models on the preliminary public providing worth to cowl over-allotments, if any.
While the Company might pursue an preliminary business mixture goal in any business or business, the Company intends to focus on corporations on the intersection of expertise and client well being and wellness. The proceeds of the preliminary public providing will likely be used to fund the business mixture.
The models started buying and selling on the Nasdaq Global Market underneath the ticker image “PEPLU” on October 15, 2021. Each unit consists of 1 Class A bizarre share of the Company and one-half of 1 warrant. Each entire warrant entitles the holder thereof to buy one Class A bizarre share of the Company at a worth of $11.50 per share. Once the securities comprising the models start separate buying and selling, the Class A bizarre shares and warrants are anticipated to be listed on the Nasdaq Global Market underneath the symbols “PEPL” and “PEPLW,” respectively.
Oppenheimer & Co. Inc. acted as the only underwriter for the providing.
The providing was made solely by way of a prospectus. A replica of the ultimate prospectus associated to the providing could also be obtained from: Oppenheimer & Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, phone: (212) 667-8055 or electronic mail: [email protected].
A registration assertion regarding the providing has been filed with, and declared efficient by, the U.S. Securities and Exchange Commission (the “SEC”) on October 14, 2021. Copies of the registration assertion, as amended, might be accessed by the SEC’s web site at www.sec.gov. This press launch shall not represent a proposal to promote or the solicitation of a proposal to purchase, nor shall there be any sale of those securities in any state or jurisdiction through which such provide, solicitation, or sale can be illegal previous to registration or qualification underneath the securities legal guidelines of any such state or jurisdiction.
This press launch incorporates statements that represent “forward-looking statements,” together with with respect to the anticipated use of the online proceeds. No assurance might be provided that the online proceeds of the providing will likely be used as indicated. Forward-looking statements are topic to quite a few circumstances, a lot of that are past the management of the Company, together with these set forth within the Risk Factors part of the Company’s registration assertion and any prospectus for the Company’s providing filed with the SEC. Copies can be found on the SEC’s web site, www.sec.gov. The Company undertakes no obligation to replace these statements for revisions or adjustments after the date of this launch, besides as required by regulation.
Contact
PepperLime Health Acquisition Corporation
www.pepperlimehealth.com
Ramzi Haidamus
(415) 263-9939
Related Images
Image 1: PepperLime Health Logo
This content material was issued by the press launch distribution service at Newswire.com.
